4th Quarter - Report
NVG, LLC for PHRMA
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Combatting Antimicrobial Resistance, Pasteur Act, (S. 4760).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA F. HURVITZ | — |
| ANDREA LARUE | — |
Copyright/Patent/Trademark CPT
Intellectual property and patent eligibility, generally; Affordable Prescriptions for Patients Through Promoting Competition Act (H.R. 4398), (H.R. 5133); Affordable Prescriptions for Patients Act of 2019 (S. 1416)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA F. HURVITZ | — |
| ANDREA LARUE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.